Anti-Leukemia Activity of In Vitro-Expanded Human Gamma Delta T Cells in a Xenogeneic Ph+ Leukemia Model
2011

Gamma Delta T Cell Therapy for Ph+ Leukemia

Sample size: 9 publication 10 minutes Evidence: moderate

Author Information

Author(s): Gabrielle M. Siegers, Tania C. Felizardo, A. Mark Mathieson, Yoko Kosaka, Xing-Hua Wang, Jeffrey A. Medin, Armand Keating

Primary Institution: Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada

Hypothesis

Can in vitro-expanded human gamma delta T cells effectively treat Ph+ leukemia in a xenogeneic model?

Conclusion

In vitro-expanded gamma delta T cells showed selective cytotoxicity against Ph+ leukemia cells and decreased leukemia burden in treated mice.

Supporting Evidence

  • Gamma delta T cells were expanded in vitro and shown to be cytotoxic against Ph+ leukemia cell lines.
  • Therapy with gamma delta T cells resulted in decreased leukemia burden in treated mice.
  • Expanded gamma delta T cells persisted in the mouse model for up to 33 days.

Takeaway

Scientists are testing a new type of immune cell therapy to help fight a specific kind of leukemia, and it seems to work better than traditional methods.

Methodology

The study involved expanding gamma delta T cells from healthy donors and testing their effectiveness against Ph+ leukemia cells in a mouse model.

Potential Biases

Potential bias due to the small number of donors and the specific model used.

Limitations

The study had a limited sample size and the therapy did not show a significant survival advantage.

Participant Demographics

Healthy adult donors were used to obtain gamma delta T cells.

Statistical Information

P-Value

p=0.3563

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016700

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication